Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 6/20 | 0.46 |
| ▸ | HPGD | P15428 | 6/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CCR1 | P32246 | 1/20 | 0.42 |
| ▸ | CCR5 | P51681 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30531496 | 1.00 | AHR (0.47) | AHRMAPTHPGDKDM4EALDH1A1 | |
| SCHEMBL21019565 | 0.92 | AHR (0.44) | AHRMAPTHPGDKDM4EALDH1A1 | |
| SCHEMBL17472509 | 0.91 | HCRTR1 (0.54) | AHRMAPTHPGDKDM4EALDH1A1 | |
| SCHEMBL17486247 | 0.90 | NPC1 (0.53) | AHRMAPTHPGDKDM4EALDH1A1 | |
| SCHEMBL21019348 | 0.86 | AHR (0.42) | AHRMAPTHPGDKDM4EALDH1A1 | |
| SCHEMBL15696765 | 0.86 | CYP2A6 (0.45) | MAPTHPGDKDM4EALDH1A1NPC1 | |
| SCHEMBL23542943 | 0.86 | DHODH (0.43) | AHRMAPTHPGDKDM4EALDH1A1 | |
| SCHEMBL15696837 | 0.86 | KDM4E (0.46) | AHRHPGDKDM4EALDH1A1NPC1 | |
| SCHEMBL15696775 | 0.86 | PRMT5 (0.41) | AHRHPGDKDM4EALDH1A1MEN1 | |
| SCHEMBL15696773 | 0.86 | CYP2A6 (0.47) | MAPTHPGDKDM4EALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4701391-A2 | HETEROLEPTIC IRIDIUM COMPLEX | Universal Display Corporation (US) | 2026-02-25 | — | — | EP | disclosed |
| US-12550604-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2026-02-10 | — | — | US | disclosed |
| EP-3643721-B1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORP (US) | 2026-01-28 | — | — | EP | disclosed |
| US-20240180020-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-05-30 | — | — | US | disclosed |
| US-11910701-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2024-02-20 | — | — | US | disclosed |
| US-20230309376-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-28 | — | — | US | disclosed |
| US-20230309376-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-28 | — | — | US | disclosed |
| CN-112028941-B | Heteroleptic iridium complexes | 通用显示公司 | 2023-08-29 | — | — | CN | disclosed |
| US-11637251-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-04-25 | — | — | US | disclosed |
| US-11637251-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-04-25 | — | — | US | disclosed |
| US-20140203268-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2014-07-24 | — | — | US | disclosed |
| US-8722205-B2 | Heteroleptic iridium complex | UNIVERSAL DISPLAY CORPORATION (US) | 2014-05-13 | — | — | US | disclosed |
| US-8722205-B2 | Heteroleptic iridium complex | UNIVERSAL DISPLAY CORPORATION (US) | 2014-05-13 | — | — | US | disclosed |
| US-8722205-B2 | Heteroleptic iridium complex | UNIVERSAL DISPLAY CORPORATION (US) | 2014-05-13 | — | — | US | disclosed |
| EP-2411401-A1 | HETEROLEPTIC IRIDIUM COMPLEX | Universal Display Corporation (US) | 2012-02-01 | — | — | EP | disclosed |
| US-20100244004-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100244004-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100244004-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2010-09-30 | — | — | US | disclosed |
| WO-2010111175-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2010-09-30 | — | — | WO | disclosed |
| WO-2010111175-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2010-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11910701-B2 | Organic electroluminescent materials and devices | ICOSLG, PDCD1LG2, NECTIN4 | AHR 1612/4885MAPT 910/4885HPGD 2170/4885 |
| US-20240180020-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ICOSLG, PDCD1LG2, NECTIN4 | AHR 1612/4885MAPT 910/4885HPGD 2170/4885 |
| US-11637251-B2 | Organic electroluminescent materials and devices | ICOSLG, PDCD1LG2, NECTIN4 | AHR 1612/4885MAPT 910/4885HPGD 2170/4885 |
| US-20230309376-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ICOSLG, PDCD1LG2, NECTIN4 | AHR 1612/4885MAPT 910/4885HPGD 2170/4885 |
| US-20100244004-A1 | HETEROLEPTIC IRIDIUM COMPLEX | DDT, ICOSLG, PDCD1LG2 | AHR 625/4885MAPT 744/4885HPGD 2166/4885 |
| US-12550604-B2 | Organic electroluminescent materials and devices | ROS1, DNMT3A, PRDM9 | AHR 794/4885MAPT 1607/4885HPGD 4115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.